ECP as a marker of bronchitis hypersensitivity in children under 4 years of age;Białko kationowe eozynofilów (ECP) jako marker nadwrażliwości oskrzeli u dzieci do lat 4

Pediatria Wspolczesna

Volumn 3, Issue 3, 2001, Pages 213-217

  Wasowska Królikowska, Krystyna ^a   Dynowski, Jarosław ^a   Tomaszewska, Monika ^a   Kowalska, Ewa ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Asthma in children; Eosinophil cationic protein (ECP)

Indexed keywords

EID: 84863206889     PISSN: 15075532     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Fal A.M., Panaszek B.: Eozynofile. [w:] red. Małolepszy J.: Choroby alergiczne i astma. Volumed, Wrocław, 1996, 65-78.
2. Mygind N., Dahl R., Pedersen S. i wsp.: Alergologia. Urban & Partner, Wrocław, 1998, 1-60, 109-130.
3. Frigas E., Loegering D.A., Gleich G.J.: Cytotoxic properties of the eosinophil major basic protein on tracheal epithelium. Lab. Invest., 1980, 42, 35-43.
4. Venge P.: Soluble markers of allergic inflammation. Allergy, 1994, 49, 1-8.
5. Negro R. del, Tognella S., Micheletto C. i wsp.: Serum ECP and bronchial hyperresponsiveness to hypoosmolar challange in naive atopic asthmatics. Investing. Clin. Immunol., 1998, 8, 294-299.
6. Yoshikawa T., Shoji S., Fuji T. i wsp.: Severity of exercise-induced bronchoconstriction is related to airway eosinophilic inflammation in patients with asthma. Eur. Respir. J., 1998, 12, 879-884.
7. Marciniak D., Tomaszewicz-Fryca J., Płusa T. i wsp.: Eosinophil cationic protein in children with allergic diseases of the respiratory tract in exacerbation and remission of symptoms. Pol. Merkuriusz Lek., 1998, 4, 75-77.
8. Ferguson A.C., Vaugham R., Brown H. i wsp.: Evaluation of serum eosinophilic cationic protein as a marker of disease activity in chronic asthma. J. Allergy Clin. Immunol., 1995, 95, 23-28.
9. Metzger W.J., Richerson A.B., Worden K. i wsp.: BAL of allergic asthmatic patients following allergen provocation. Chest., 1986, 89, 477-483.
10. Oddera S., Silvestri M., Penna R. i wsp.: Airway eosinophilic inflammation and bronchial hyperresponsivness after allergen inhalation challenge in asthma. Lung, 1998, 176 (4), 237-247.
11. Vourdas D., Syriogou E., Potamianou P. i wsp.: Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standarized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. Allergy, 1998, 53, 662-672.
12. Prehn A., Seger R.A., Faber J. i wsp.: The relationship of serumeosinophil cationic protein and eosinophil count to disease activity in children with bronchial asthma. Pediatr. Allergy Immunol., 1998, 9, 197-203.
13. Oymar K., Bjerknes R.: Is serum eosinophil cationic protein in bronchiolitis a predictor of asthma? Pediatr. Allergy Immunol., 1998, 9, 204-207.
14. Hoekstra M.O., Grol M.H., Hovenga H. i wsp.: Eosinophil and mast cell parameters in children with stable moderate asthma. Pediatr. Allergy Immunol., 1998, 9, 143-149.
15. Bootsma G.P., Koenderman L., Dekhuijzen P.N. i wsp.: Effects of fluticasone propionate and beclomethasone dipropionate on parameters of inflammation in peripheral blood of patients with asthma. Allergy, 1998, 53, 653-661.
16. Shibahara S., Fujisawa T., Terada A. i wsp.: Theophylline reduces serum levels of ECP in vitro. Arerugi, 1998, 47, 518-523.
17. Laitinen L., Laitinen A., Neino M. i wsp.: Eosinophilic airway inflammation during exacerbation of asthma and its treatment with inhaled corticosteroids. Am. Rev. Respir. Dis., 1991, 143, 423-427.
18. Khalife J., Capron M., Cesbron J.Y. i wsp.: Role of specific IgE antybodies in peroxidase (EPO) relese form human eosinophils. J. Immunol., 1986, 137, 1659-1664.